A Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients with Relapsed/Refractory Multiple Myeloma
Clinical Trial Grant
Awarded By
Gilead Sciences, Inc.
Start Date
October 12, 2022
End Date
October 31, 2027
Awarded By
Gilead Sciences, Inc.
Start Date
October 12, 2022
End Date
October 31, 2027